[42] similarly showed clear differences between their control and cell-treated cohorts, resulting in a significant improvement of about 20-point ODI 3.5 years following cell therapy, while the control group showed a trend of about 10-point ODI worsening.
← all excerpts
Comprehensive narrative review on the analysis of outcomes from cell transplantation clinical trials for discogenic low back pain.
3
—
—
The sentences
Again, focusing on the cell treatment complementing microdiscectomy, a clear trend of improvement in outcomes can be observed.
treating microdiscectomy patients with autologous IVD derived-cells, was similarly able to report alleviation in pain (a 42% reduction), which resulted only in a slight trend of enhanced pain outcomes compared to a discectomy-only cohort.